12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
周三盘后交易时段,12只医疗保健类股走势
Gainers
获胜者
- PLx Pharma (NASDAQ:PLXP) stock increased by 10.6% to $0.23 during Wednesday's after-market session. The market value of their outstanding shares is at $6.5 million.
- Clovis Oncology (NASDAQ:CLVS) shares rose 9.76% to $0.12. Trading volume for this security closed at 5.4 million, accounting for 125.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.7 million.
- OpGen (NASDAQ:OPGN) stock increased by 9.09% to $0.18. Today's trading volume for this security ended up closing at 2.9 million shares, which is 72.0 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $9.6 million.
- Champions Oncology (NASDAQ:CSBR) shares rose 8.26% to $4.98. The market value of their outstanding shares is at $67.3 million. The company's, Q2 earnings came out yesterday.
- Humanigen (NASDAQ:HGEN) stock moved upwards by 8.18% to $0.14. At the close, Humanigen's trading volume reached 120.5K shares. This is 3.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $16.3 million.
- Owlet (NYSE:OWLT) shares rose 6.78% to $0.71. The market value of their outstanding shares is at $81.5 million.
- PLx Pharm 纳斯达克股票代码:PLXP)股价在周三的盘后交易中上涨了10.6%,至0.23美元。他们已发行股票的市值为650万美元。
- 克洛维斯肿瘤学 纳斯达克股票代码:CLVS)股价上涨9.76%,至0.12美元。该证券的交易量收于540万笔,占过去100天平均全日交易量的125.9%。他们已发行股票的市值为1,670万美元。
- opGen 纳斯达克股票代码:OPGN)股价上涨9.09%,至0.18美元。该证券今天的交易量最终收于290万股,占过去100天平均交易量的72.0%。他们已发行股票的市值为960万美元。
- 冠军肿瘤学 纳斯达克股票代码:CSBR)股价上涨8.26%,至4.98美元。他们已发行股票的市值为6,730万美元。该公司昨天公布了第二季度的收益。
- Humanigen 纳斯达克股票代码:HGEN)股价上涨8.18%,至0.14美元。收盘时,Humanigen的交易量达到12.5万股。这是过去 100 天平均交易量的 3.2%。他们已发行股票的市值为1,630万美元。
- 猫头鹰 纽约证券交易所代码:OWLT)股价上涨6.78%,至0.71美元。他们的已发行股票的市值为8150万美元。
Losers
失败者
- Novavax (NASDAQ:NVAX) shares fell 13.3% to $14.94 during Wednesday's after-market session. This security traded at a volume of 598.6K shares come close, making up 11.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.1 billion.
- Intelligent Bio Solutions (NASDAQ:INBS) shares decreased by 8.5% to $0.32. The market value of their outstanding shares is at $5.8 million.
- Vallon Pharmaceuticals (NASDAQ:VLON) shares declined by 6.8% to $0.48. Vallon Pharmaceuticals's trading volume hit 21.2 million shares by close, accounting for 4115.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $6.1 million.
- TransCode Therapeutics (NASDAQ:RNAZ) stock declined by 5.85% to $0.43. The company's market cap stands at $5.5 million.
- ImmuCell (NASDAQ:ICCC) stock fell 5.01% to $6.26. The company's market cap stands at $48.4 million.
- Vincerx Pharma (NASDAQ:VINC) stock declined by 5.0% to $0.83. Trading volume for this security closed at 541.7K, accounting for 274.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.5 million. See Also:
- Novavax 纳斯达克股票代码:NVAX)股价在周三的盘后交易中下跌13.3%,至14.94美元。该证券的交易量为598.6万股,占过去100天平均交易量的11.8%。他们已发行股票的市值为11亿美元。
- 智能生物解决方案 纳斯达克股票代码:INBS)股价下跌8.5%,至0.32美元。他们已发行股票的市值为580万美元。
- 瓦隆制药 纳斯达克股票代码:VLON)股价下跌6.8%,至0.48美元。Vallon Pharmicals的交易量收盘时达到2,120万股,占过去100天平均交易量的4115.0%。他们已发行股票的市值为610万美元。
- TransCode 治疗学 纳斯达克股票代码:RNAZ)股价下跌5.85%,至0.43美元。该公司的市值为550万美元。
- ImmuCell 纳斯达克股票代码:ICCC)股价下跌5.01%,至6.26美元。该公司的市值为4,840万美元。
- Vincerx Parma 纳斯达克股票代码:VINC)股价下跌5.0%,至0.83美元。该证券的交易量收于541.7万,占过去100天平均全日交易量的274.8%。他们已发行股票的市值为1,750万美元。 另请参阅:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。